SCHEMBL73136

SCHEMBL73136

C[CH]C1=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL52900 0.83
SCHEMBL1025593 0.81
SCHEMBL8184246 0.81 GSTP1 (0.32)
SCHEMBL8184429 0.81 GSTP1 (0.32)
SCHEMBL954497 0.81 GSTP1 (0.32)
SCHEMBL73139 0.79
SCHEMBL6589574 0.69
SCHEMBL11081134 0.68
SCHEMBL1285605 0.67
SCHEMBL12869926 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4281066-A2 ARTEMISININ-PROTEASOME INHIBITOR CONJUGATES AND THEIR USE IN THE TREATMENT OF DISEASE Cornell University (US) 2023-11-29 EP disclosed
CN-111491628-B Phenoxy acids for the treatment of neuromuscular disorders NMD制药股份公司 2023-10-13 CN disclosed
US-11591284-B2 Compounds for the treatment of neuromuscular disorders NMD PHARMA A/S (DK) 2023-02-28 US disclosed
EP-3723746-B1 PHENOXY ACIDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA AS (DK) 2022-02-23 EP disclosed
EP-3723746-A1 PHENOXY ACIDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD Pharma A/S (DK) 2020-10-21 EP disclosed
CN-111491628-A Phenoxy acids for the treatment of neuromuscular disorders NMD制药股份公司 2020-08-04 CN disclosed
US-20190183812-A1 Compounds For The Treatment Of Neuromuscular Disorders NMD PHARMA A/S (DK) 2019-06-20 US disclosed
WO-2019115780-A1 PHENOXY ACIDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS NMD PHARMA A/S (DK) 2019-06-20 WO disclosed
US-20190185409-A1 Compounds For The Treatment Of Neuromuscular Disorders NMD PHARMA APS (DK) 2019-06-20 US disclosed
EP-3110810-B1 PYRAZOLE AMIDE DERIVATIVE TEIJIN PHARMA LTD (JP) 2018-05-02 EP disclosed
US-5750540-A SIDE EFFECT REDUCTION BANYU PHARMACEUTICAL CO., LTD. (JP) 1998-05-12 US disclosed
EP-0823423-A1 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1998-02-11 EP disclosed
US-5659021-A Chiral glycerol derivatives THE BOARD OF GOVERNORS FOR HIGHER EDUCATION, STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS (US) 1997-08-19 US disclosed
EP-0731102-A1 Cyclic phenol sulfide and process for producing the same COSMO RESEARCH INSTITUTE (JP) 1996-09-11 EP disclosed
US-4931575-A Chiral glycerol derivatives THE BOARD OF GOVERNORS FOR HIGHER EDUCATION, STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS (US) 1990-06-05 US disclosed
US-4190579-A Synthesis of beta-lactams from azetidine carboxylic acid esters RESEARCH CORPORATION (US) 1980-02-26 US disclosed
US-4183931-A SEDATIVE-HYPNOTICS, ANTICONVULSANTS, CENTRAL NERVOUS SYSTEM DEPRESSANTS RESEARCH CORPORATION (US) 1980-01-15 US disclosed
US-4178286-A β-Lactams, their production, intermediates thereto and derivatives thereof RESEARCH CORPORATION (US) 1979-12-11 US disclosed
US-4165371-A ANALGESICS RESEARCH CORPORATION (US) 1979-08-21 US disclosed
US-4163743-A Beta-lactams, their production from azetidine carboxylic acids, intermediates thereto and derivatives thereof RESEARCH CORPORATION (US) 1979-08-07 US disclosed